Brain–computer interfacing

Neurotechnology Introduces BrainAccess Development Kit for Brain-Computer Interface Applications

Retrieved on: 
Wednesday, August 12, 2020
Branches of biology, Neuroscience, Brain–computer interfacing, Electrophysiology, Neurophysiology, Electrodiagnosis, Electroencephalography, Brain, Neurotechnology, Brain–computer interface

VILNIUS, Lithuania, Aug. 12, 2020 /PRNewswire/ -- Neurotechnology today announced the launch of the BrainAccess Development Kit.

Key Points: 
  • VILNIUS, Lithuania, Aug. 12, 2020 /PRNewswire/ -- Neurotechnology today announced the launch of the BrainAccess Development Kit.
  • This kit offers high-density coverage of all cerebral cortex regions offering development capabilities of more elaborate BCI experiments or applications.
  • The BrainAccess Development Kit comes with all of the necessary software for EEG data acquisition and processing and also features some BCI algorithms.
  • BrainAccess Core Library provides an interface with BrainAccess electroencephalographs and allows for direct access of recorded EEG data.

Stratus™ Now Offers In-Network Coverage for Veterans

Retrieved on: 
Tuesday, July 28, 2020
Branches of biology, Neuroscience, Medicine, Brain–computer interfacing, Electroencephalography, Electrophysiology, Neurophysiology, Neurotechnology, Telemetry

This nationwide area of coverage means Veteran policyholders will now have more affordable and convenient access to the innovative in-home video EEG testing and mobile cardiac telemetry services Stratus has to offer.

Key Points: 
  • This nationwide area of coverage means Veteran policyholders will now have more affordable and convenient access to the innovative in-home video EEG testing and mobile cardiac telemetry services Stratus has to offer.
  • "We are proud to have the opportunity to provide Veterans across the U.S. with affordable, high-quality in-home neurodiagnostic testing.
  • Many of these Veterans live in rural and smaller communities that do not have local access to high-level neurodiagnostic testing services.
  • Payment coverage for in-home video EEG testing through Stratus means Vets can test in the comfort of their own home with most appointments available within 24-72 hours of scheduling.

Synchron Secures Further Funding from the Australian Government to Advance Commercialization of Stentrode

Retrieved on: 
Thursday, July 23, 2020
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Human–computer interaction, User interface techniques, Biomedical engineering, Medical technology, Brain–computer interfacing, Neuroprosthetics, Biological engineering, Neural engineering, Thomas Oxley, Stent-electrode recording array, Brain–computer interface

We are excited to be able to progress the development of the first fully-implantable commercial brain computer interface, said Thomas Oxley, MD, PhD, CEO of Synchron.

Key Points: 
  • We are excited to be able to progress the development of the first fully-implantable commercial brain computer interface, said Thomas Oxley, MD, PhD, CEO of Synchron.
  • This support from the Australian government will accelerate the delivery of this new therapeutic paradigm to patients with this devastating and irreversible condition.
  • As the Stentrode system is small and flexible enough to safely pass through curving blood vessels, insertion of the Stentrode does not require open brain surgery.
  • Headquartered in Silicon Valley, California, Synchron has a presence at Newlab in Brooklyn, New York and R&D facilities in Melbourne, Australia.

Paradromics Unveils The Largest Ever Electrical Recordings in Cortex

Retrieved on: 
Monday, July 20, 2020
Neuroscience, Branches of biology, Neuroprosthetics, Brain–computer interfacing, Cerebral cortex, Biomedical engineering, Neurophysiology, Neural engineering, Electrophysiology

AUSTIN, Texas, July 20, 2020 /PRNewswire/ -- Paradromics, Inc, an Austin, TX-based startup, just unveiled the largest ever electrical recording of cortical activity, using the highest capacity neural recording system.

Key Points: 
  • AUSTIN, Texas, July 20, 2020 /PRNewswire/ -- Paradromics, Inc, an Austin, TX-based startup, just unveiled the largest ever electrical recording of cortical activity, using the highest capacity neural recording system.
  • Paradromics' first product will be a communication device for patients with severe paralysis.
  • The team has recently uploaded a manuscript to bioRxiv , showcasing the scalability of Paradromics' technology platform, which will be adapted for clinical use as early as 2023.
  • Paradromics demonstrates an electrical recording from over 30,000 electrode channels in sheep cortex.

EDO Releases First-of-Its-Kind Engagement Tracker for Streaming Originals

Retrieved on: 
Thursday, June 25, 2020
Branches of biology, Articles, Neuroscience, Brain–computer interfacing, Electroencephalography, Electrophysiology, Neurophysiology, Neurotechnology, Analytics

EDO has already signed two of the largest streaming services to a confidential beta pilot program that began in early April of this year.

Key Points: 
  • EDO has already signed two of the largest streaming services to a confidential beta pilot program that began in early April of this year.
  • With the launch of EEG, EDO continues to apply world-class data science to powerful behavioral metrics to help its clients generate greater value from their creative investments and promotional efforts.
  • As competition among streaming services and studios ratchets up the stakes, these entertainment companies continue to seek innovative data solutions.
  • EDO is a data, measurement and analytics company that powers the success of marketing, research and creative professionals.

Kelyniam Global Releases Q1 Financials - Returns to Profitability

Retrieved on: 
Thursday, June 18, 2020
Human–computer interaction, Neuroscience, Technology, Neuroprosthetics, Emerging technologies, Brain–computer interfacing, Neural engineering, Biomedical engineering, Prosthesis, Brain implant, Computer-aided

CANTON, Conn., June 18, 2020 /PRNewswire/ --Kelyniam Global (KLYG), a maker of custom cranial implants, released today financial performance for the first quarter of the 2020.

Key Points: 
  • CANTON, Conn., June 18, 2020 /PRNewswire/ --Kelyniam Global (KLYG), a maker of custom cranial implants, released today financial performance for the first quarter of the 2020.
  • "Even with just 10 weeks of sales, better expense management and fewer legal costs contributed to the company returning to profitability for the quarter," said Bjella.
  • Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers.
  • Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes.

BioSerenity, Leader in Healthcare as a Service (HaaS), Helps Advance Understanding of COVID-19 Neurological Impact

Retrieved on: 
Thursday, June 18, 2020
Branches of biology, Medicine, Clinical medicine, Brain–computer interfacing, Electroencephalography, Electrophysiology, Neurophysiology, Neurotechnology, Sedation

Via these collaborations, we were one of the first to discover EEG anomalies likely associated with Covid-19.

Key Points: 
  • Via these collaborations, we were one of the first to discover EEG anomalies likely associated with Covid-19.
  • Patients presented with altered mental status, had delayed awakening, or poor arousal after being taken off sedation.
  • BioSerenity will provide data to help physicans diagnose over 30,000 patients suffering from neurological disorders this year.
  • Headquartered in Paris, France, and Atlanta, GA, USA, BioSerenity is an innovative medical technology company focused on Healthcare as a Service, IoMT, A.I.

Brain Scientific Updates Disposable EEG Headset Sales Plan, Supply Scale-Up, and IP Status

Retrieved on: 
Wednesday, June 17, 2020
Branches of biology, Medicine, Clinical medicine, Brain–computer interfacing, Electrophysiology, Neurophysiology, Neurotechnology, Psychiatric assessment, Electroencephalography, Epilepsy, Epileptic seizure

To address expected heightened demand for disposable medical products brought on by the COVID-19 pandemic, Brain Scientific is fast-tracking steps required for expedited commercialization of its FDA cleared NeuroCap, single-use, disposable EEG headset.

Key Points: 
  • To address expected heightened demand for disposable medical products brought on by the COVID-19 pandemic, Brain Scientific is fast-tracking steps required for expedited commercialization of its FDA cleared NeuroCap, single-use, disposable EEG headset.
  • Patent applications for Brain Scientifics disposable EEG sets are pending in the U.S. (Application No.
  • EEGs are among the most widely used tests to diagnose brain conditions, such as seizures, epilepsy, headaches, brain tumors, and sleeping problems.
  • NeuroCap is an FDA-cleared disposable EEG headset with 22 electrodes and 19 active EEG channels.

NeuroOne Medical Technologies Corporation Appoints Dr. Camilo Andres Diaz-Botia, Former Lead of Process Engineering at Neuralink, as Director of Electrode Development

Retrieved on: 
Tuesday, June 16, 2020
Technology, Research, Medical devices, Nanotechnology, Biotechnology, Hardware, Health, General Health, Science, Businesspeople, Articles, Brain–computer interfacing, Technology, Elon Musk, Neuralink, Transhumanism, Human–computer interaction, User interface techniques, Brain–computer interface, Microfabrication, Engineering

Previously, Dr. Diaz-Botia led the microfabrication process engineering team at Neuralink Corp., a Company founded by Elon Musk, working on developing a high bandwidth brain machine interface.

Key Points: 
  • Previously, Dr. Diaz-Botia led the microfabrication process engineering team at Neuralink Corp., a Company founded by Elon Musk, working on developing a high bandwidth brain machine interface.
  • We are thrilled to have such a highly regarded neural engineering expert to lead our development team, says Dave Rosa, president and CEO, NeuroOne.
  • Camilo brings in-depth knowledge and expertise in the design of implantable thin film electrodes.
  • At Neuralink Corp., Dr. Diaz-Botia led and mentored the process engineering team to deliver projects with unique microfabrication processes.

Bionic Sight, LLC Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Blindness caused by Retinitis Pigmentosa

Retrieved on: 
Tuesday, June 16, 2020
Nervous system, Organ systems, Branches of biology, Neuroscience, Neuroprosthetics, Brain–computer interfacing, Control theory, Cybernetics, Optogenetics, Nerve

Bionic Sights therapy delivers the optogenetic proteins to the optic nerve, which sends the signals to the brain.

Key Points: 
  • Bionic Sights therapy delivers the optogenetic proteins to the optic nerve, which sends the signals to the brain.
  • A key issue for producing meaningful vision is to send signals to the brain that the brain can understand.
  • The Companys Phase 1/2 trial is an open-label, dose escalation study in patients diagnosed with advanced stage RP.
  • AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in ophthalmology, otology and CNS disorders.